Login / Signup

A matching-adjusted indirect comparison of acalabrutinib versus zanubrutinib in relapsed or refractory chronic lymphocytic leukemia.

Adam S KittaiAlan SkarbnikMiguel MirandaAlan S M YongJack RoosRobert HettleSarah Palazuelos-MunozVikram ShettyPaolo Ghia
Published in: American journal of hematology (2023)
Keyphrases
  • chronic lymphocytic leukemia
  • acute lymphoblastic leukemia
  • acute myeloid leukemia
  • multiple myeloma
  • diffuse large b cell lymphoma
  • hodgkin lymphoma